Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ: CMPS )

8.205 -0.125 (-1.50%)
Streaming Delayed Price Updated: 11:12 AM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 60,590
Open 8.280
Bid (Size) 8.190 (1)
Ask (Size) 8.220 (2)
Prev. Close 8.330
Today's Range 8.170 - 8.390
52wk Range 6.540 - 21.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The "Rags-To-Riches" Portfolio: An Update
Cannabis, psychedelic, and plant-based food stocks performed extremely poorly in 2022, down 73% vs. 2021 but perhaps some of them will bounce back with major returns in 2023. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
 
Via Benzinga

Performance

YTD
+6.28%
+6.28%
1 Month
-10.13%
-10.13%
3 Month
-11.68%
-11.68%
6 Month
-39.31%
-39.31%
1 Year
-40.80%
-40.80%

More News

Read More
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
Via Benzinga
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression
Via Benzinga
Where Compass Pathways Stands With Analysts
Via Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Via Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
Via Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Via Benzinga
Compass Pathways - Entering A Brave New World
Via Talk Markets
Psychedelic Stock Gainers And Losers From March 6, 2023
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Via Benzinga
2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market
Via The Motley Fool
2 Growth Stocks With Incredible Potential in the Next 5 Years
Via The Motley Fool
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
Via Benzinga
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials
Via Benzinga
Compass Pathways Plc (CMPS) Q4 2022 Earnings Call Transcript
Via The Motley Fool
COMPASS Pathways Announces Fourth Quarter and Year-End 2022 Financial Results and Business Highlights
From COMPASS Pathways
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.